Search clinical trials for: ENDS Product F with 1.5% nicotine
Total 29 results
-
RAI Services CompanyCompletedSmoking | Tobacco UseUnited States
-
Imperial Brands PLCRecruitingHealthy VolunteersUnited Kingdom
-
Société des Produits Nestlé (SPN)Completed
-
University of California, Los AngelesTobacco Related Disease Research ProgramCompleted
-
Eclat Srl.University of CataniaRecruitingDiabetes Mellitus, Type 2 | Cardiovascular Risk FactorUnited Kingdom
-
Christian CasanovaCompletedElectronic Cigarette Use | Retina; ChangeCanada
-
Eclat Srl.University of CataniaNot yet recruitingPeriodontal Diseases | GingivitisItaly
-
Taro Pharmaceuticals USACompleted
-
Altria Client Services LLCCelerionRecruiting
-
University of Alabama at BirminghamTerminatedContact Lens AdaptationUnited States
-
Altria Client Services LLCCato ResearchCompletedTobacco UseUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedDental Caries | Dental FluorosisBrazil
-
Queen's University, BelfastFour Seasons Health CareUnknownNeurodegenerative Diseases | DementiaUnited Kingdom
-
Indiana UniversityChildren's Hospital of PhiladelphiaRecruiting
-
Washington State UniversityNational Center for Complementary and Integrative Health (NCCIH); Office of...Active, not recruitingInteraction Drug FoodUnited States
-
University of Split, School of MedicineGeneral Hospital ZadarUnknownEpilepsy | Cerebral Palsy | Diabetes Mellitus, Type 1 | Stress | Asthma | Chronic Disease | Autism Spectrum Disorder | Down Syndrome | Developmental Disability | Pervasive Developmental DisorderCroatia
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedMetastatic Gastric CancerTaiwan
-
NovoBliss Research Pvt LtdNanobrid Innovations Private LimitedNot yet recruiting
-
Ramathibodi HospitalCompletedRadical MastectomyThailand
-
University of WashingtonRecruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruiting
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States, Canada, Australia, New Zealand, Switzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome NegativeUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)SuspendedDown Syndrome | Recurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand